// App-Quantinova.ai

e21567 : Can polymetastatic disease be arrested using SABR? A dosimetric analysis to inform development of a phase I trial.

Researchers

Presenter

  • Mark Thomas Corkum

Principal Investigators

  • Hatim Fakir

  • David A. Palma

  • Timothy K. Nguyen

  • Glenn Bauman

Medical Centers

  • London Regional Cancer Centre, London, ON, Canada

  • Department of Pathology, London Health Sciences Centre, London, ON, Canada

  • London Health Sciences Center, London, ON, Canada

  • Western University, London Regional Cancer Program, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A